MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Endo International plc - Company Profile (NASDAQ:ENDP)

Consensus Ratings for Endo International plc - (NASDAQ:ENDP) (?)
Ratings Breakdown: 11 Hold Rating(s), 9 Buy Rating(s)
Consensus Rating:Hold (Score: 2.45)
Consensus Price Target: $41.74 (157.79% upside)

Analysts' Ratings History for Endo International plc - (NASDAQ:ENDP)
Show:
DateFirmActionRatingPrice TargetActions
6/28/2016BMO Capital MarketsInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2016JPMorgan Chase & Co.Reiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016Deutsche BankReiterated RatingBuy$31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/13/2016MizuhoUpgradeUnderperform -> Neutral$13.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Goldman SachsInitiated CoverageNeutral$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2016RBC CapitalReiterated RatingSector Perform$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2016Stifel NicolausLower Price TargetBuy$75.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2016Morgan StanleyReiterated RatingHold$50.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2016JMP SecuritiesReiterated RatingBuy$56.00 -> $52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2016BarclaysReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2016Leerink SwannDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2016GuggenheimReiterated RatingBuy$65.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2016Piper JaffrayDowngradeOverweight -> Neutral$79.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2016Citigroup Inc.Lower Price TargetBuy$72.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/2/2016NomuraReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/22/2016OppenheimerReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2016William BlairReiterated RatingHold$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2016Northland SecuritiesReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/1/2016Canaccord GenuityReiterated RatingBuy$67.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/20/2015SusquehannaLower Price Target$70.00 -> $68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2015Standpoint ResearchUpgradeHold -> Buy$75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2015Raymond JamesInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/22/2015Cantor FitzgeraldBoost Price TargetHold$80.00 -> $92.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015Keefe, Bruyette & WoodsBoost Price TargetOutperform$94.00 -> $101.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/2/2015CRT CapitalBoost Price TargetFair Value$73.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2014Sterne Agee CRTBoost Price Target$1.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for Endo International plc - (NASDAQ:ENDP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/5/2016Q116$1.04$1.08$960.96 million$963.54 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/29/2016Q415$1.27$1.36$1.07 billion$1.07 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315$1.00$1.02$736.16 million$746.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215$1.02$1.08$727.45 million$735.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q115$1.07$1.17$714.42 million$714.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/2/2015Q414$1.12$1.16$780.44 million$800.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2014Q314$0.99$1.15$721.11 million$764.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q214$0.88$1.06$644.60 million$719.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q114$0.84$0.92$608.86 million$595.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2014Q413$0.93$0.96$620.90 million$584.95 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q313$1.11$1.34$695.63 million$715.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2013Q2 2013$1.15$1.42$721.01 million$766.51 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2013Q1 2013$1.08$1.09$737.79 million$709.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2013Q4 2012$1.54$1.62$807.98 million$801.06 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2012Q312$1.26$1.28$788.53 million$750.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2012$1.19$1.27ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2012$0.86$0.87ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2012$1.32$1.40ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2011$1.28$1.25ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/9/2011$1.06$1.05ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2011$1.00$1.00ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2011$0.97$1.06ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Endo International plc - (NASDAQ:ENDP)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$1.05$1.15$1.09
Q2 20163$0.79$1.37$1.13
Q3 20163$1.10$1.59$1.36
Q4 20164$1.58$1.88$1.77
(Data provided by Zacks Investment Research)
Dividend History for Endo International plc - (NASDAQ:ENDP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Endo International plc - (NASDAQ:ENDP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/11/2016Arthur J HigginsDirectorBuy5,000$13.80$69,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2016Arthur J HigginsDirectorBuy11,000$15.42$169,620.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2016Paul CampanelliInsiderBuy13,000$15.53$201,890.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2016William SpenglerDirectorBuy1,000$29.20$29,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2016William SpenglerDirectorBuy1,000$35.24$35,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2016Roger H KimmelDirectorBuy1,125$41.94$47,182.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2016Matthew Joseph MalettaVPBuy500$44.48$22,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2016Silva Rajiv DeCEOBuy2,250$44.50$100,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/1/2016Nancy J. HutsonDirectorSell3,413$42.19$143,994.47View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2015Shane CookeDirectorBuy4,000$57.13$228,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2015Michael HyattDirectorSell8,000$55.48$443,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2015Paul CampanelliinsiderBuy2,100$55.69$116,949.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2015Silva Rajiv DeCEOBuy9,006$55.52$500,013.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2015Suketu UpadhyayCFOBuy4,450$56.37$250,846.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2015Susan HallEVPBuy1,000$55.35$55,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2015Arthur J HigginsDirectorBuy2,500$81.10$202,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2015Caroline B ManogueVPSell105,562$91.90$9,701,147.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2014Suketu UpadhyayCFOBuy3,700$66.94$247,678.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2014Arthur J HigginsDirectorBuy3,500$65.65$229,775.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2014John DeluccaDirectorSell6,764$68.83$465,566.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2014Caroline B ManogueVPSell175,033$72.02$12,605,876.66View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014John DeluccaDirectorSell8,094$66.31$536,713.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2014John DeluccaDirectorSell10,384$68.46$710,888.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2014Arthur HigginsDirectorBuy5,000$73.00$365,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2014Ivan GergelEVPSell75,637$72.47$5,481,413.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2013Caroline ManogueVPSell145,592$39.40$5,736,324.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2013Roger KimmelDirectorBuy5,478$36.50$199,947.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/9/2013Caroline B ManogueVPSell35,000$35.00$1,225,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2012David HolveckCEOBuy7,425$26.84$199,287.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Endo International plc - (NASDAQ:ENDP)
DateHeadline
06/28/16 08:50 PMWhy Endo International plc Patented a Higher Stock Price
06/28/16 03:45 PMEndo International Sharply Higher
06/28/16 03:45 PMEndo Int'l (ENDP) Unit Receives New U.S. Patent Related to Vasostrict
06/28/16 03:26 PMUS STOCKS-Wall St bounces back after two-day Brexit rout -
06/28/16 02:36 PMEndo International Jumps on Patent Approval, Still Has Work to Do -
06/28/16 02:21 PMEndo Int'l (ENDP) Stock Spikes on New FDA Patent -
06/28/16 01:57 PMHey, Endo, Stop Copying Valeant -
06/28/16 01:57 PMEndo International: Finally…Some Good News! -
06/28/16 12:14 PMGilead gets approval for hep C drug -
06/28/16 11:51 AMEndo Announces Issuance of Vasostrict® Patent - [at noodls] - DUBLIN, June 28, 2016 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced that one of its operating companies, Par Pharmaceutical, has been issued a new patent by the U.S. ...
06/28/16 08:42 AMExclusive: Specialty drugmaker Endo explores asset sales - sources
06/27/16 04:49 PMExclusive: Speciality drugmaker Endo explores asset sales - sources -
06/27/16 02:26 PMWatch Out For Extreme Volatility In Lipocine On Tuesday -
06/27/16 08:18 AMAnalysts View on Drug Manufacturers - Other Equities - Endo Intl., Teva Pharma, Synergy Pharma, and Orexigen Therapeutics
06/24/16 09:07 PMENDO SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Endo International plc - ENDP - [Marketwired] - Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 25, 2016 to file lead plaintiff applications in a securities ...
06/24/16 04:43 PMSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Endo International plc of Class Action Lawsuit and Upcoming Deadline - ENDP - [Accesswire] - NEW YORK, NY / ACCESSWIRE / June 24, 2016 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of Endo International plc ("Endo" or the "Company") (NASDAQ: ...
06/24/16 12:57 PMJuly 25 Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming Deadline in the Class Action Lawsuit against Endo International plc - [Business Wire] - Law Offices of Howard G. Smith reminds investors of the upcoming July 25, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class of investors who purchased Endo International plc securities between March 2, 2015 and May 6, 2016, inclusive .
06/24/16 10:37 AMCovering the Bases on Endo International plc (NASDAQ:ENDP): Where is the Stock Going? - Press Telegraph
06/24/16 10:37 AMPrice Target Review: Endo International plc (NASDAQ:ENDP) - News Oracle
06/24/16 10:37 AMRecent Analysts Rating Overview: Endo International plc (NASDAQ:ENDP) , Envision Healthcare Holdings, Inc. (NYSE ... - Street Updates
06/24/16 10:26 AMSHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Endo International plc and a Lead Plaintiff Deadline of July 25, 2016 - [Business Wire] - The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Endo International plc securities between March 2, 2015 and May 6, 2016.
06/23/16 02:48 PMEndo International plc (NASDAQ:ENDP): Share Update and Performance Review - Press Telegraph
06/23/16 02:48 PMEquity Research and Technical Review on Endo International plc (NASDAQ:ENDP) - Press Telegraph
06/23/16 02:48 PMAnalyst's Stocks Rating Activity: Endo International plc (NASDAQ:ENDP) , Allergan plc. (NYSE:AGN) - Street Updates
06/23/16 10:15 AMValeant Pharmaceuticals: Now You Downgrade It? -
06/23/16 05:58 AMWill Endo International plc (NASDAQ:ENDP) Surprise Analysts? - Investor Newswire
06/23/16 05:58 AMStock in the Spotlight: Endo International plc (NASDAQ:ENDP) - News Oracle
06/22/16 09:00 PMBig Earnings Movers: Endo International plc (ENDP)
06/22/16 03:56 PMRSI Alert: Endo International (ENDP) Now Oversold
06/22/16 08:31 AMAnalysts Observing Trading Stocks: Endo International plc (NASDAQ:ENDP) , Immunomedics, Inc. (NASDAQ:IMMU) - Street Updates
06/21/16 03:37 PMActive Healthcare Concerns Warier- Endo International (NASDAQ:ENDP), Gilead Sciences (NASDAQ:GILD) - Seneca Globe
06/21/16 03:37 PMRSI Alert: Endo International (ENDP) Now Oversold - Forbes
06/21/16 11:25 AMSHAREHOLDER NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Endo International plc And Encourages Investors With Losses In Excess of $100,000 To Contact The Firm - [Business Wire] - Khang & Khang LLP announces that a class action lawsuit has been filed against Endo International plc . Investors who purchased or otherwise acquired shares between March 2, 2015 and May 6, 2016, inclusive , are encouraged to contact the Firm prior to the July 25, 2016, lead plaintiff motion deadline.
06/21/16 08:30 AMHC Stocks Highlights: Endo International plc (NASDAQ:ENDP), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) - share market updates (press release)
06/21/16 08:30 AMReview of Analysts Ranking: Endo International plc (NASDAQ:ENDP) , Skyline Medical Inc. (NASDAQ:SKLN) - Street Updates
06/21/16 08:30 AMENDO INTERNATIONAL INVESTOR ALERT: Hagens Berman Reminds Endo International plc (NASDAQ: ENDP ... - GlobeNewswire (press release)
06/21/16 03:00 AMENDO INTERNATIONAL INVESTOR ALERT: Hagens Berman Reminds Endo International plc (NASDAQ: ENDP) Investors of July 25, 2016 Lead Plaintiff Deadline in Securities Class Action - [GlobeNewswire] - SAN FRANCISCO, June 21, 2016-- The following statement is being issued by Hagens Berman Sobol Shapiro LLP:. To: All persons or entities who purchased or otherwise acquired securities of Endo International ...
06/20/16 03:59 PMIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit Against Endo International plc and Encourages Investors With Losses in Excess of $100,000 to Contact the Firm - [Business Wire] - Khang & Khang LLP announces that a class action lawsuit has been filed against Endo International plc . Investors who purchased or otherwise acquired shares between March 2, 2015 and May 6, 2016, inclusive , are encouraged to contact the Firm prior to the July 25, 2016, lead plaintiff motion deadline.
06/20/16 03:44 PMMizuho Securities Upgrades Endo International plc - Ordinary Shares to Neutral - TheFounders Daily
06/20/16 03:44 PMBrocade Communications Systems, (NASDAQ:BRCD) & Endo International plc - Ordinary Shares (NASDAQ:ENDP ... - Wall Street 24
06/20/16 03:44 PMHC Stocks Highlights: GlobeImmune Inc (NASDAQ:GBIM), Endo International plc (NASDAQ:ENDP) - share market updates (press release)
06/20/16 03:44 PMTake a look at Analysts Tips: Endo International plc (NASDAQ:ENDP) , Pernix Therapeutics Holdings, Inc. (NASDAQ ... - Street Updates
06/20/16 10:44 AMINVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Class Action Involving Endo International plc and a Lead Plaintiff Deadline of July 25, 2016 - ENDP - [GlobeNewswire] - NEW YORK, June 20, 2016-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased ...
06/17/16 03:38 PMHow high can Endo International plc – Ordinary Shares (NASDAQ:ENDP) stock go’ Analysts hold 85.00
06/17/16 07:46 AMEndo International plc - Ordinary Shares (NASDAQ:ENDP) & Cellectar Biosciences (NASDAQ:CLRB) Healthcare ... - Wall Street 24
06/17/16 07:46 AMIs Endo International PLC (ENDP) A Turnaround Opportunity? - Insider Monkey (blog)
06/16/16 09:02 PMPIMCO in no rush to sell negative yielding bonds
06/16/16 03:48 PMGoldberg Law PC Announces Securities Class Action Lawsuit Against Endo International plc and Encourages Investors With Losses to Contact the Firm
06/16/16 02:06 PMSHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Endo International plc and Encourages Investors With Losses to Contact the Firm - [Business Wire] - Goldberg Law PC announces that a class action lawsuit has been filed against Endo International plc . Investors who purchased or otherwise acquired shares between March 2, 2015 and May 6, 2016, , are encouraged to contact the firm in advance of the July 25, 2016, lead plaintiff motion deadline.
06/16/16 12:24 PMIs Endo International PLC (ENDP) A Turnaround Opportunity? -
About Endo International plc -

Endo International plc - logoEndo International PLC, formerly Endo Health Solutions Inc. is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel. The Company operates in three segments: Endo Pharmaceuticals, Qualitest and AMS. In June 2014, the Company's subsidiary, Endo Pharmaceuticals sold its pharmaceutical drug discovery platform to AsanaBioSciences, LLC. In June 2014, Asana BioSciences, LLC, an independent member of Amneal Alliance of Companies, acquired early-stage branded pharmaceutical discovery platform of Endo Pharmaceuticals, a subsidiary of Endo International plc. In June 2014, Trendlines Group acquired intellectual property developed within the framework of an R&D agreement with the Company. In July 2014, it acquired Grupo Farmaceutico Somar.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: ENDP
  • CUSIP: 29264F20
Key Metrics:
  • Previous Close: $16.19
  • 50 Day Moving Average: $15.86
  • 200 Day Moving Average: $36.58
  • P/E Ratio: N/A
  • P/E Growth: 0.36
  • Market Cap: $3.60B
  • Current Quarter EPS Consensus Estimate: $4.58 EPS
Additional Links:
Endo International plc - (NASDAQ:ENDP) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha